SCHEMBL2767679

SCHEMBL2767679

Oc1cc(F)c(N2CCC(C=CCc3ccccc3)CC2)cc1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
MGLL Q99685 1/20 0.35
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HDAC8 Q9BY41 2/20 0.34
KMT2A Q03164 2/20 0.34
ALOX15 P16050 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34
OPRL1 P41146 1/20 0.34
TOP1 P11387 1/20 0.34
GRM5 P41594 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CHRM4 P08173 1/20 0.33
MAOB P27338 1/20 0.33
RORC P51449 2/20 0.33
NPY2R P49146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2767675 1.00 LMNA (0.35) LMNAMGLLALDH1A1SMN1; SMN2HPGD
SCHEMBL2767466 0.82 FFAR4 (0.46) ALDH1A1SMN1; SMN2L3MBTL1KMT2AALOX15
SCHEMBL2768139 0.80 MAPT (0.50) MGLLSMN1; SMN2KMT2AHTTMAPT
SCHEMBL2766662 0.76 SLC18A3 (0.48) CHRM4
SCHEMBL2767637 0.72 HTR1A (0.54) ALDH1A1KMT2AMAPT
SCHEMBL2768505 0.68 KMT2A (0.71) LMNAALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL2768562 0.68 LMNA (0.50) LMNAKMT2AHTTHSD17B10RORC
SCHEMBL11234537 0.67 MAOB (0.52) ALDH1A1HPGDHSD17B10MAOBPOLB
SCHEMBL9137069 0.67 MAOB (0.52) ALDH1A1HPGDHSD17B10MAOBPOLB
SCHEMBL9137067 0.67 MAOB (0.52) ALDH1A1HPGDHSD17B10MAOBPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA LMNA 3963/4885MGLL 2816/4885ALDH1A1 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.